{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:43:46Z","timestamp":1790649826264,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1378\/chest.127.3.1064","type":"journal-article","created":{"date-parts":[[2005,3,12]],"date-time":"2005-03-12T01:58:48Z","timestamp":1110592728000},"page":"1064-1071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":252,"title":["Treatment of Sarcoidosis With Infliximab"],"prefix":"10.1016","volume":"127","author":[{"given":"John D","family":"Doty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A","family":"Judson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.127.3.1064_bib1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0272-5231(05)70422-6","article-title":"Treatment with corticosteroids","volume":"18","author":"Winterbauer","year":"1997","journal-title":"Clin Chest Med"},{"key":"10.1378\/chest.127.3.1064_bib2","first-page":"623","article-title":"An approach to the treatment of pulmonary sarcoidosis with corticosteroids","volume":"111","author":"Judson","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.127.3.1064_bib3","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.127.3.1064_bib4","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/archinte.1997.00440370104011","article-title":"Diagnosis and management of neurological sarcoidosis","volume":"157","author":"Lower","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.127.3.1064_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1055\/s-2002-36518","article-title":"Ocular manifestations of sarcoidosis","volume":"23","author":"Bradley","year":"2002","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1378\/chest.127.3.1064_bib6","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/archderm.1997.03890430098013","article-title":"Cutaneous involvement in sarcoidosis: relationship to systemic disease","volume":"133","author":"Mana","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1378\/chest.127.3.1064_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0272-5231(05)70423-8","article-title":"Steroid-sparing alternative treatments for sarcoidosis","volume":"18","author":"Baughman","year":"1997","journal-title":"Clin Chest Med"},{"key":"10.1378\/chest.127.3.1064_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00000441-199003000-00002","article-title":"The use of low-dose methotrexate in refractory sarcoidosis","volume":"299","author":"Lower","year":"1990","journal-title":"Am J Med Sci"},{"key":"10.1378\/chest.127.3.1064_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1055\/s-2002-36521","article-title":"Sarcoidosis of the thyroid and kidneys and calcium metabolism","volume":"23","author":"Sharma","year":"2002","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1378\/chest.127.3.1064_bib10","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1378\/chest.124.5.2023","article-title":"Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen","volume":"124","author":"Doty","year":"2003","journal-title":"Chest"},{"key":"10.1378\/chest.127.3.1064_bib11","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.168.9.4620","article-title":"TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection","volume":"168","author":"Roach","year":"2002","journal-title":"J Immunol"},{"key":"10.1378\/chest.127.3.1064_bib12","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1164\/ajrccm.155.5.9154873","article-title":"Pentoxifylline in treatment of sarcoidosis","volume":"155","author":"Zabel","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.127.3.1064_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1378\/chest.122.1.227","article-title":"Thalidomide for chronic sarcoidosis","volume":"122","author":"Baughman","year":"2002","journal-title":"Chest"},{"key":"10.1378\/chest.127.3.1064_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2002.004226","article-title":"Tumour necrosis factor-\u03b1 inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients","volume":"63","author":"Pritchard","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.127.3.1064_bib15","first-page":"75","article-title":"Defining organ involvement in sarcoidosis: the ACCESS proposed instrument","volume":"16","author":"Judson","year":"1999","journal-title":"Sarc Vasc Diffuse Lung Dis"},{"key":"10.1378\/chest.127.3.1064_bib16","first-page":"747","article-title":"Current concepts of the pathogenesis of sarcoidosis","volume":"135","author":"Thomas","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.127.3.1064_bib17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0092-8674(89)90676-4","article-title":"The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection","volume":"56","author":"Kindler","year":"1989","journal-title":"Cell"},{"key":"10.1378\/chest.127.3.1064_bib18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1164\/ajrccm.152.3.7663784","article-title":"Alveolar macrophage TNF-\u03b1 release and BAL cell phenotypes in sarcoidosis","volume":"152","author":"Zheng","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.127.3.1064_bib19","first-page":"36","article-title":"Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis","volume":"115","author":"Baughman","year":"1990","journal-title":"J Lab Clin Med"},{"key":"10.1378\/chest.127.3.1064_bib20","first-page":"70","article-title":"Infliximab for refractory sarcoidosis","volume":"18","author":"Baughman","year":"2001","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1378\/chest.127.3.1064_bib21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1067\/mjd.2003.228","article-title":"Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-\u03b1 therapy","volume":"48","author":"Mallbris","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1378\/chest.127.3.1064_bib22","first-page":"413","article-title":"The use of infliximab in cutaneous sarcoidosis","volume":"2","author":"Meyerle","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1378\/chest.127.3.1064_bib23","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1378\/chest.124.5.2028","article-title":"Refractory sarcoidosis responding to infliximab","volume":"124","author":"Roberts","year":"2003","journal-title":"Chest"},{"key":"10.1378\/chest.127.3.1064_bib24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/archneur.60.3.426","article-title":"The pathogenesis and treatment of optic disc swelling in neurosarcoidosis: a unique therapeutic response to infliximab","volume":"60","author":"Katz","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1378\/chest.127.3.1064_bib25","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/01.WNL.0000034766.13282.33","article-title":"Refractory neurosarcoidosis responding to infliximab","volume":"59","author":"Pettersen","year":"2002","journal-title":"Neurology"},{"key":"10.1378\/chest.127.3.1064_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-135-1-200107030-00010","article-title":"Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-\u03b1 therapy","volume":"135","author":"Yee","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.127.3.1064_bib27","first-page":"A495","article-title":"Double-blind, randomized trial of a tumor necrosis factor receptor antagonist (etanercept) for treatment of chronic ocular sarcoidosis [abstract]","volume":"165","author":"Baughman","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.127.3.1064_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1378\/chest.124.1.177","article-title":"Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis","volume":"124","author":"Utz","year":"2003","journal-title":"Chest"},{"key":"10.1378\/chest.127.3.1064_bib29","first-page":"241","article-title":"Molecular differences in anticytokine therapies","volume":"21","author":"Calabrese","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1378\/chest.127.3.1064_bib30","first-page":"A613","article-title":"Effects of antibodies to infliximab on safety and efficacy of infliximab treatment in patients with Crohn's disease [abstract]","volume":"122","author":"Wagner","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1378\/chest.127.3.1064_bib31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa020888","article-title":"Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease","volume":"348","author":"Baert","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.127.3.1064_bib32","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.127.3.1064_bib33","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1164\/rccm.200206-563OC","article-title":"Histoplasmosis after treatment with anti-tumor necrosis factor-\u03b1 therapy","volume":"167","author":"Wood","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.127.3.1064_bib34","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1002\/art.10679","article-title":"Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration","volume":"46","author":"Brown","year":"2002","journal-title":"Arthritis Rheum"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215311235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215311235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:46:21Z","timestamp":1757918781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215311235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0012369215311235"],"URL":"https:\/\/doi.org\/10.1378\/chest.127.3.1064","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Sarcoidosis With Infliximab","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.127.3.1064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}